Future of an effective Coronavirus Vaccine remains Uncertain after Death during Vaccine Trials

Future of an effective Coronavirus Vaccine remains Uncertain after Death during Vaccine Trials

Future of an effective Coronavirus Vaccine remains Uncertain after Death during Vaccine Trials

Globe Live Media, Oct.22– As the end of the year draws to a close, the eyes of people all over the World are also looking for an effective Coronavirus vaccine, many companies around the world are putting strenuous efforts to get the Covid-19 vaccine ready, some companies have even announced about reaching the final stage of their Vaccine Trials.

Amidst all this, a huge news related to the vaccine has come from Brazil, it has been reported from Brazil that One person died on Wednesday during the trial of a Coronavirus vaccine which was being made by the University of Oxford and AstraZeneca, the age of the person is 28 years, the person was working as a doctor in hospitals in Rio de Janeiro city of Brazil and had been treating patients of Covid-19 since March, during these treatments he got infected with the corona virus.

But if the news is to be believed, He was not given a Covid-19 vaccine made by AstraZeneca and Oxford, rather He was given a placebo vaccine, although AstraZeneca has made a statement that it cannot tell about any participant of the vaccine trial in public and also said that there will be no hindrance in the vaccine trial due to this incident, the trial will continue.

Oxford, which is making the vaccine with AstraZeneca, also said in its statement that the Brazilian vaccine trial incident would not affect the vaccine trials, the vaccine is absolutely safe, and the trials would continue.

Let me tell you that earlier in September during the trial of AstraZeneca and Oxford Vaccine in the UK, one participant got an uncertain sickness, but later an independent review of Britain revealed that the person did not get the disease due to the vaccine.
Nevertheless, the United States stopped the vaccine trial of AstraZeneca and Oxford in the US after the incident.

AstraZeneca and Oxford vaccine trials have been conducted so far on a total of 6,000 people in Brazil, and trials have been conducted on 20,000+ people worldwide.

Let us also tell you that the US has currently stopped vaccine trials of AstraZeneca and Oxford University in the US, AstraZeneca and Oxford are yet to be given a green signal by US regulators to start back trials.

Amidst all the complexities in the Trials of the AstraZeneca and Oxford Vaccine, the future of an effective Coronavirus Vaccine still remains Uncertain.